Work

Implementing DPYD/UGT1A1testing to prevent treatment related adverse events (TRAE) in patients with gastrointestinal (GI) cancer: Results of a pragmatic implementation trial.

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.16_suppl.10599

Authors: Sony Tuteja, Mari Angelica Cayabyab, Glenda Hoffecker, Lisa Varughese, Victoria Wittner, Jean De Dieu Ndayishimiye, Xingmei Wang, Margaret Harr, Avni Santani, Hakon Hakonarson, Ryan Campbell Massa, Nevena Damjanov, Nandi J. Reddy, Randall A. Oyer, Ursina R. Teitelbaum

Institutions: University of Pennsylvania, Hospital of the University of Pennsylvania, Children's Hospital of Philadelphia, Abramson Cancer Center, Lancaster General Hospital

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Penn Center for Precision Medicine, University of Pennsylvania

OpenAlex ID: W4401338259

Cites:

Cited by:

Related to: 10